GlassScriptPhysician profile
Terry S Jackson
NPI 1932106234
$1,193.63
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $782 · 2020: $239 · 2021: $30.94 · 2022: $125 · 2023: $16.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $213.29 | 2019-2020 | |
| Novo Nordisk INC | $141.96 | 2019-2022 | |
| Pfizer INC. | $108.19 | 2019 | |
| Sunovion Pharmaceuticals INC. | $99.53 | 2019 | |
| Abbvie INC. | $85.43 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $72.48 | 2019-2020 | |
| Amgen INC. | $63.14 | 2019-2023 | Repatha, Otezla |
| Dexcom, INC. | $46.92 | 2019-2020 | |
| Abbott Laboratories | $40.32 | 2019-2022 | |
| Astellas Pharma US INC | $40.24 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $39.83 | 2019 | |
| Merck Sharp & Dohme LLC | $38.50 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.60 | 2022 | |
| Mylan Specialty L.P. | $34.82 | 2019 | |
| Janssen Pharmaceuticals, INC | $33.32 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $23.95 | 2019 | |
| Lilly USA, LLC | $23.87 | 2019 | |
| Daiichi Sankyo INC. | $21.36 | 2019 | |
| Radius Health, INC. | $15.33 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.